Paricalcitol attenuates indoxyl sulfate-induced apoptosis through the inhibition of MAPK, Akt, and NF-kB activation in HK-2 cells
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Indoxyl sulfate (IS) is a uremic toxin and an important causative factor in the progression of chronic kidney disease. Recently, paricalcitol (19-nor-1,25-dihydroxyvitamin D2) was shown to exhibit protective effects in kidney injury. Here, we investigated the effects of paricalcitol treatment on IS-induced renal tubular injury. Methods: The fluorescent dye 2ʹ,7ʹ-dichlorofluorescein diacetate was used to measure intracellular reactive oxygen species (ROS) following IS administration in human renal proximal tubular epithelial (HK-2) cells. The effects of IS on cell viability were determined using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays and levels of apoptosis-related proteins (Bcl-2-associated protein X [Bax] and B-cell lymphoma 2 [Bcl-2]), nuclear factor-κB (NF- κB) p65, and phosphorylation of mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) were determined by semiquantitative immunoblotting. The promoter activity of NF-κB was measured by luciferase assays and apoptosis was determined by f low cytometry of cells stained with f luorescein isothiocyanate- conjugated Annexin V protein. Results: IS treatment increased ROS production, decreased cell viability and induced apoptosis in HK-2 cells. IS treatment increased the expression of apoptosis- related protein Bax, decreased Bcl-2 expression, and activated phosphorylation of MAPK, NF-κB p65, and Akt. In contrast, paricalcitol treatment decreased Bax expression, increased Bcl-2 expression, and inhibited phosphorylation of MAPK, NF-κB p65, and Akt in HK-2 cells. NF-κB promoter activity was increased following IS, administration and was counteracted by pretreatment with paricalcitol. Additionally, flow cytometry analysis revealed that IS-induced apoptosis was attenuated by paricalcitol treatment, which resulted in decreased numbers of fluorescein isothiocyanate-conjugated Annexin V positive cells. Conclusions: Treatment with paricalcitol inhibited IS-induced apoptosis by regulating MAPK, NF-κB, and Akt signaling pathway in HK-2 cells.
Abstract
Background/Aims: Indoxyl sulfate (IS) is a uremic toxin and an important causative factor in the progression of chronic kidney disease. Recently, paricalcitol (19-nor-1,25-dihydroxyvitamin D2) was shown to exhibit protective effects in kidney injury. Here, we investigated the effects of paricalcitol treatment on IS-induced renal tubular injury. Methods: The fluorescent dye 2ʹ,7ʹ-dichlorofluorescein diacetate was used to measure intracellular reactive oxygen species (ROS) following IS administration in human renal proximal tubular epithelial (HK-2) cells. The effects of IS on cell viability were determined using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays and levels of apoptosis-related proteins (Bcl-2-associated protein X [Bax] and B-cell lymphoma 2 [Bcl-2]), nuclear factor-κB (NF- κB) p65, and phosphorylation of mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) were determined by semiquantitative immunoblotting. The promoter activity of NF-κB was measured by luciferase assays and apoptosis was determined by f low cytometry of cells stained with f luorescein isothiocyanate- conjugated Annexin V protein. Results: IS treatment increased ROS production, decreased cell viability and induced apoptosis in HK-2 cells. IS treatment increased the expression of apoptosis- related protein Bax, decreased Bcl-2 expression, and activated phosphorylation of MAPK, NF-κB p65, and Akt. In contrast, paricalcitol treatment decreased Bax expression, increased Bcl-2 expression, and inhibited phosphorylation of MAPK, NF-κB p65, and Akt in HK-2 cells. NF-κB promoter activity was increased following IS, administration and was counteracted by pretreatment with paricalcitol. Additionally, flow cytometry analysis revealed that IS-induced apoptosis was attenuated by paricalcitol treatment, which resulted in decreased numbers of fluorescein isothiocyanate-conjugated Annexin V positive cells. Conclusions: Treatment with paricalcitol inhibited IS-induced apoptosis by regulating MAPK, NF-κB, and Akt signaling pathway in HK-2 cells.
참고문헌 (35)
- Mutsaers HA, "Chronic kidney disease and fibrosis : the role of uremic retention solutes", Front Med(Lausanne), 2, pp.60~ (2015)
- Ellis RJ, "Indoxyl sulphate and kidney disease : causes, consequences and interventions", Nephrology(Carlton), 21, pp.170~177 (2016)
- Vanholder R, "The uremic toxicity of indoxyl sulfate and p-cresyl sulfate : a systematic review", J Am Soc Nephrol, 25, pp.1897~1907 (2014)
- Niwa T, "Uremic toxicity of indoxyl sulfate", Nagoya J Med Sci, 72, pp.1~11 (2010)
- Ito S, "Protein-bound uremic toxins : new culprits of cardiovascular events in chronic kidney disease patients", Toxins(Basel), 6, pp.665~678 (2014)
- Enomoto A, "Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity", J Am Soc Nephrol, 13, pp.1711~1720 (2002)
- Niwa T, "Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis", J Lab Clin Med, 124, pp.96~104 (1994)
- Taki K, "Accumulation of indoxyl sulfate in OAT1", 3-positive tubular cells in kidneys of patients with chronic renal failure, 2006, pp.16, 199~203
- Shimizu H, "NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells", Am J Physiol Cell Physiol, 301, pp.C1201~C1212 (2011)
- Vaziri ND, "Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension", Kidney Int, 53, pp.1748~1754 (1998)
- Jofre R, "Inflammatory syndrome in patients on hemodialysis", J Am Soc Nephrol, 17, pp.S274~S280 (2006)
- Gelasco AK, "Indoxyl sulfate induces complex redox alterations in mesangial cells", Am J Physiol Renal Physiol, 290, pp.F1551~F1558 (2006)
- Shimizu H, "Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate", Am J Physiol Cell Physiol, 299, pp.C1110~C1117 (2010)
- Ito S, "Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin", J Biol Chem, 285, pp.38869~38875 (2010)
- Wang WJ, "DPP-4 inhibitor attenuates toxic effects of indoxyl sulfate on kidney tubular cells", PLoS One, 9, pp.e93447~ (2014)
- Kim SH, "Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease", Lab Invest, 92, pp.488~498 (2012)
- Himmelfarb J, "The elephant in uremia : oxidant stress as a unifying concept of cardiovascular disease in uremia", Kidney Int, 62, pp.1524~1538 (2002)
- Vaziri ND, "Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency", Kidney Int, 63, pp.179~185 (2003)
- Tan X, "Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling", J Am Soc Nephrol, 19, pp.1741~1752 (2008)
- Nolan KA, "Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia", Exp Cell Res, 330, pp.371~381 (2015)
- He W, "Blockade of Wnt", β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury, 2011, pp.22, 90~103
- Park JW, "Paricalcitol attenuates cyclosporine-induced kidney injury in rats", Kidney Int, 77, pp.1076~1085 (2010)
- Kim CS, "Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells", PLoS One, 8, pp.e63186~ (2013)
- 김창성, "Vitamin D and chronic kidney disease", The Korean Journal of Internal Medicine, 29(4), pp.416~427 (2014), 대한내과학회[DOI]
- Nakagawa Y, "Current topics on vitamin D : vitamin D and chronic kidney disease", Clin Calcium, 25, pp.413~423 (2015)
- Shimizu H, "Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence", Am J Nephrol, 36, pp.184~189 (2012)
- Shimizu H, "Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-κB and p53 in proximal tubular cells", Life Sci, 92, pp.143~148 (2013)
- Cuzzocrea S, "Antioxidant therapy : a new pharmacological approach in shock, inflammation, and ischemia", reperfusion injury, 2001, pp.53, 135~159
- Harrison D, "Role of oxidative stress in atherosclerosis", Am J Cardiol, 91, pp.7~ (2003)[DOI]
- Lassègue B, "Reactive oxygen species in hypertension; an update", Am J Hypertens, 17, pp.852~860 (2004)
- Miyamoto Y, "The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal-physiological conditions", FEBS Lett, 584, pp.2816~2820 (2010)
- Guo C, "Melamine causes apoptosis of rat kidney epithelial cell line(NRK-52e cells)via excessive intracellular ROS(reactive oxygen species)and the activation of p38 MAPK pathway", Cell Biol Int, 36, pp.383~389 (2012)
- Lu Y, "Arsanilic acid causes apoptosis and oxidative stress in rat kidney epithelial cells(NRK-52e cells)by the activation of the caspase-9 and-3signaling pathway", Drug Chem Toxicol, 37, pp.55~62 (2014)
- Skaug B, "The role of ubiquitin in NF-kappaB regulatory pathways", Annu Rev Biochem, 78, pp.769~796 (2009)
- Wei MC, "Proapoptotic BAX and BAK : a requisite gateway to mitochondrial dysfunction and death", Science, 292, pp.727~730 (2001)